Follow
Connor Clemett
Connor Clemett
Unknown affiliation
Verified email at transaxon.bio
Title
Cited by
Cited by
Year
Astrocyte-selective AAV-ADAMTS4 gene therapy combined with hindlimb rehabilitation promotes functional recovery after spinal cord injury
JM Griffin, B Fackelmeier, CA Clemett, DM Fong, A Mouravlev, D Young, ...
Experimental Neurology 327, 113232, 2020
322020
Synthesis and biological evaluation of S-lipidated lipopeptides of a connexin 43 channel inhibitory peptide
SH Yang, CA Clemett, MA Brimble, SJ O'Carroll, PWR Harris
RSC Medicinal Chemistry 11 (9), 1041-1047, 2020
82020
Synthesis and Biological Evaluation of Termini-Modified and Cyclic Variants of the Connexin43 Inhibitor Peptide5
SH Crystal Chan, JM Griffin, CA Clemett, MA Brimble, SJ O’Carroll, ...
Frontiers in Chemistry 10, 877618, 2022
12022
DIGESTION OF CHONDROITIN SULPHATE PROTEOGLYCANS BY AAV5-ADAMTS4 GENE THERAPY ENHANCES NON-NEURONAL RESPONSES TO CONTUSIVE SPINAL INJURY
C Clemett, J Sheehan, B Fackelmeier, D Fong, A Mouravlev, D Young, ...
JOURNAL OF NEUROTRAUMA 39 (15-16), A15-A15, 2022
2022
Digestion of chondroitin sulphate proteoglycans by AAV5-GfaABC1D-ADAMTS4 gene therapy enhances non-neuronal responses to contusive spinal injury.
CA Clemett
PhD Thesis-University of Auckland, 2022
2022
Viral vector gene therapy approaches for regeneration and repair in spinal cord injury
SJ O’Carroll, CA Clemett
Diagnosis and Treatment of Spinal Cord Injury, 411-423, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–6